| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6064180 | Journal of Allergy and Clinical Immunology | 2015 | 12 Pages |
Abstract
Risk of uncontrolled asthma at 3 months and a severe exacerbation within 12 months can be estimated from simple clinical assessments. Prospective validation of these predictive factors and the RSE is required. Use of these models might guide the management of asthmatic patients.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Eric D. MD, Roland MD, Paul M. MB, FRCPC, Marc MD, Helen K. MBBS, PhD, FRACP, Malcolm R. MB, FRACP, FRCPC, Christine MD, FRACP, Tim W. MD, Santiago MD, PhD, Stefan PhD, Göran MB, PhD,